Dr. Christopher Brooks

Pet Releaf, the CBD hemp health brand for pets, announced that Christopher Brooks, DVM has joined the company as vice president of Pet Releaf Professional Sales effective immediately. In this newly created role, Dr. Brooks will build and lead the company's salesforce for Sentesa, the first offering in its professional product line exclusively for veterinarians that launched this year. He will continue to spearhead the sales team and initiatives as the company develops and introduces new innovations in this family of products that helps veterinarians manage their patient’s inflammatory response, calmness, joint flexibility and mobility, and discomfort.

Dr. Brooks is an accomplished senior leader with extensive experience in the pet, veterinary pharmaceuticals, pet nutrition, and pet cannabis industries. He brings 30 years of experience to Pet Releaf, joining the company from Canopy Animal Health where he was one of six founding team members tasked with forging the animal health company for the Canopy Growth Corporation. Prior to that experience, Dr. Brooks held a variety of senior leadership positions in sales, distribution management, national accounts, medical affairs, training and development at Merial, Boehringer Ingelheim Animal Health and Hill’s Pet Nutrition. He holds a Doctor of Veterinary Medicine Degree from North Carolina State University. 

"We are thrilled to welcome Chris to the Pet Releaf leadership team; his expertise and talent will be critical as we grow our new Professional product line for veterinarians," said Stephen Smith, president and co-founder at Pet Releaf.